Shockwave Medical, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2018 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Shockwave Medical, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2018 to Q1 2024.
  • Shockwave Medical, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was $55.3M, a 41.5% increase year-over-year.
  • Shockwave Medical, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was $163M, a 32% decline year-over-year.
  • Shockwave Medical, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $147M, a 31.8% decline from 2022.
  • Shockwave Medical, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $216M.
  • Shockwave Medical, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$9.14M, a 86.1% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $163M $55.3M +$16.2M +41.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $147M $44.3M -$96.6M -68.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 $244M $35M -$17K -0.05% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $244M $28.9M +$3.3M +12.9% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $241M $39.1M +$24.6M +169% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $216M $141M +$128M +989% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 $88M $35M +$33.1M +1697% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $55M $25.6M +$26M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $29M $14.5M +$38.1M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 -$9.14M $12.9M +$28.8M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 -$38M $1.95M +$14.9M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$52.8M -$425K +$17.7M +97.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$70.5M -$23.6M -$4.83M -25.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$65.7M -$15.9M -$1.13M -7.66% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 -$64.6M -$12.9M +$25K +0.19% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$64.6M -$18.1M -$7.51M -70.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$57.1M -$18.8M -$5.98M -46.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$51.1M -$14.7M -$3.52M -31.4% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 -$47.6M -$13M -$2.78M -27.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$44.8M -$10.6M -$501K -4.96% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 -$44.3M -$12.8M -$3.21M -33.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 -$41.1M -$11.2M Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 -$10.2M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 -$10.1M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 -$9.59M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.